Oktober 2009 - IOZK

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination

2009-10-27/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2009-10-27 / J. Immunol. Methods 2010 Jan;352(1-2):169-73

Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma

2009-10-14/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-10-14 / Biol. Blood Marrow Transplant. 2010 Mar;16(3):320-32

Oncolytic virus therapy for prostate cancer

2009-10-13/in International Publications, Newcastle Disease Virus, Prostate Cancer /von 2009-10-13 / Int. J. Urol. 2010 Jan;17(1):20-30

Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma

2009-10-06/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2009-10-06 / Mol. Ther. 2010 Feb;18(2):275-84

Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma

2009-10-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-15

Immunizing against breast cancer: a new swing for an old sword

2009-10-01/in Breast Cancer, Dendritic Cells, International Publications /von 2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-4

Dendritic cell therapy of high-grade gliomas

2009-10-01/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2009-10-01 / Brain Pathol. 2009 Oct;19(4):694-712

Immunotherapy of diffuse gliomas: biological background, current status and future developments

2009-10-01/in Glioblastoma, International Publications /von 2009-10-01 / Brain Pathol. 2009 Oct;19(4):674-93

An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme

2009-10-01/in Glioblastoma, International Publications /von 2009-10-01 / Mol. Cancer Ther. 2009 Oct;8(10):2773-9

Dendritic cell-based cancer gene therapy

2009-10-01/in Dendritic Cells, International Publications /von 2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-18